在侵袭性肺腺癌前的免疫进化
Adithya Balasubramanian1, Marie-Liesse Asselin-Labat2
1Personalised Oncology Division, the Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; Department of Medical Biology, the University of Melbourne, Parkville, VIC, Australia; Department of Medical Oncology, Monash Health, Melbourne, VIC, Australia; Department of Medical Oncology, the Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Cancer cell
|May 9, 2025
概括
研究人员绘制了肺腺癌 (LUAD) 进展期间的免疫变化. 确定TIM-3为目标可以推进LUAD免疫预防策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 肺腺癌 (LUAD) 从前体病变发展为侵袭性疾病的进展尚不清楚.
- 在LUAD发育过程中,免疫系统的动态是关键的,但在很大程度上没有特征.
研究的目的:
- 在肺腺癌的进展过程中调查动态免疫微环境的变化.
- 为了确定肺腺癌免疫预防的潜在治疗点.
主要方法:
- 利用高分辨率的空间绘图技术来分析免疫细胞透和分布.
- 检查了与LUAD前体病变和侵入性瘤相关的时间免疫景观.
主要成果:
- 详细地绘制了整个LUAD进展过程中的动态免疫变化的详细地图.
- 鉴定与疾病进展相关的特定免疫标记物,包括TIM-3.
结论:
- 免疫微环境在LUAD进展中起着至关重要的作用.
- TIM-3成为开发新型肺腺癌免疫预防策略的有前途的治疗标.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


